{
    "clinical_study": {
        "@rank": "129334", 
        "arm_group": {
            "arm_group_label": "Reliance 4-Front", 
            "arm_group_type": "Other", 
            "description": "Single arm, all patients will be implanted with the Reliance 4-Front lead"
        }, 
        "brief_summary": {
            "textblock": "The objective of this study is to gather data to establish the chronic safety, performance\n      and effectiveness of the RELIANCE 4-FRONT\u2122 Active Fixation Defibrillation Leads."
        }, 
        "brief_title": "Safety and Performance Study of the Reliance 4-Front Lead", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Tachycardia", 
        "condition_browse": {
            "mesh_term": "Tachycardia"
        }, 
        "detailed_description": {
            "textblock": "The RELIANCE 4-FRONT Defibrillation Lead Post Market Clinical Follow-Up Study is a\n      prospective, non-randomized, multi-center, single-group, post market clinical study to\n      establish the chronic safety, performance and effectiveness of the RELIANCE 4-FRONT active\n      fixation defibrillation leads.\n\n      A total of 167 patients (including 10 % attrition) are required to evaluate the Primary\n      Endpoint.\n\n      Up to 20 Investigational centers located in Europe and Asia Pacific. Lead-related\n      Complication-Free Rate (CFR) from Implant through 3 Months Post-Implant.\n\n      Lead-related complications associated with the RELIANCE 4-FRONT active fixation lead will\n      count toward this endpoint.\n\n      Lead-related Complication-Free Rate from 3 Months through 15 Months Post-Implant.\n\n      Lead-related complications associated with the RELIANCE 4-FRONT active fixation lead will\n      count toward this endpoint.\n\n        -  Lead-related Complication-Free Rate from 3 Months through 24 Months Post-Implant\n\n        -  Pacing Threshold at 0.5 ms pulse width at 3 Months Post-Implant\n\n        -  Sensed Amplitude at 3 Months Post-Implant\n\n        -  Pacing Impedance at 3 Months Post-Implant All endpoints will be assessed for the\n           RELIANCE 4-FRONT active fixation lead.\n\n      Clinic visits will occur at:\n\n        -  Enrollment Visit (no later than 30 days prior to implant procedure)\n\n        -  Implant Procedure (Day 0; all future follow ups based on this date)\n\n        -  Pre-Discharge Clinic Visit (3 - 72 hours post-implant)\n\n        -  One Month Clinic Visit (30\u00b17 days)\n\n        -  3 Month Clinic Visit (91 \u00b1 21 days)\n\n        -  6 Month Clinic Visit (180 \u00b1 30 days)\n\n        -  12 Month Clinic Visit (365 \u00b1 45 days)\n\n        -  18 Month Clinic Visit (545\u00b1 45 days)\n\n        -  24 Month Clinic Visit (730 \u00b1 45 days) The study will be considered completed after all\n           subjects have completed the 24 Month follow-up and study completion is anticipated in\n           2015.  Primary endpoint completion is anticipated after all subjects have completed the\n           3 Month follow-up visit. All study required visits will be completed during clinic\n           visits.\n\n      Hypotheses testing in the RELIANCE 4-FRONT PMCF Study will use standard statistical\n      methodology as specified more in detail in the protocol."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Willing and capable of providing informed consent\n\n          -  Has an indication for implantation of a single or dual chamber ICD or  CRT-D system\n             in their respective geography\n\n          -  Subjects planned to be implanted with the RELIANCE 4-FRONT Active Fixation Lead\n\n          -  Willing and capable of participating in all testing/ visits associated with this\n             clinical study at an approved clinical study center and at the intervals defined by\n             this protocol\n\n          -  Age 18 or above, or of legal age to give informed consent specific to state and\n             national law\n\n        Exclusion Criteria:\n\n          -  Known or suspected sensitivity to Dexamethasone Acetate (DXA)\n\n          -  Mechanical tricuspid heart valve\n\n          -  Subject is enrolled in any other concurrent study without prior written approval from\n             Boston Scientific (BSC), with the exception of local mandatory governmental\n             registries and observational studies/registries that are not in conflict and do not\n             affect the following:\n\n          -  Schedule of procedures for the RELIANCE 4-Front  Study (i.e. should not cause\n             additional or missed visits);\n\n          -  RELIANCE 4-Front  Study outcome (i.e. involve medications that could affect the heart\n             rate of the subject);\n\n          -  Conduct of the RELIANCE 4-Front Study per Good Clinical Practice (GCP)/ International\n             Organization for Standardization (ISO) 14155:2011/ 21 CFR 812/ local regulations\n\n          -  Currently on the active heart transplant list\n\n          -  Documented life expectancy of less than 12 months\n\n          -  Women of childbearing potential who are or might be pregnant at the time of study\n             enrollment (method of assessment upon physician discretion)\n\n          -  Currently requiring chronic dialysis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "167", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01772576", 
            "org_study_id": "BSC-CDM00052753", 
            "secondary_id": "C1830"
        }, 
        "intervention": {
            "arm_group_label": "Reliance 4-Front", 
            "description": "The patients selected for participation should be from the investigator's general patient population with an indication for implantation of a single or dual chamber ICD or CRT-D system.", 
            "intervention_name": "Reliance 4-Front lead implantation", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Reliance", 
            "Implantable Cardioverter Defibrillator (ICD)", 
            "Cardiac Resynchronization Therapy - Defibrillator (CRT-D)"
        ], 
        "lastchanged_date": "March 11, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "St. P\u00f6lten", 
                        "country": "Austria", 
                        "zip": "3100"
                    }, 
                    "name": "Landesklinikum St. Poelten"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hong Kong", 
                        "country": "China"
                    }, 
                    "name": "Queen Mary Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aarhus", 
                        "country": "Denmark", 
                        "zip": "8200"
                    }, 
                    "name": "Aarhus University Hospitals"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Massy", 
                        "country": "France", 
                        "zip": "91300"
                    }, 
                    "name": "Institut Cardiovasculaire - Paris Sud"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }, 
                    "name": "Deutsches Herzzentrum Berlin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "30625"
                    }, 
                    "name": "Medizinische Hochschule Hannover"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ashkelon", 
                        "country": "Israel", 
                        "zip": "78306"
                    }, 
                    "name": "Barzilai Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tel Hashomer", 
                        "country": "Israel", 
                        "zip": "52621"
                    }, 
                    "name": "Sheba Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lecco", 
                        "country": "Italy", 
                        "zip": "23900"
                    }, 
                    "name": "Ospedale Alessandro Manzoni"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pisa", 
                        "country": "Italy", 
                        "zip": "56127"
                    }, 
                    "name": "Azienda Ospedaliero Universitaria Pisana"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Carnaxide", 
                        "country": "Portugal", 
                        "zip": "2790-134"
                    }, 
                    "name": "Hospital de Santa Cruz"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Malaga", 
                        "country": "Spain", 
                        "zip": "29019"
                    }, 
                    "name": "Hospital Universitario Virgen de la Victoria"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden", 
                        "zip": "17176"
                    }, 
                    "name": "Karolinska Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bristol", 
                        "country": "United Kingdom", 
                        "zip": "BS2 8HW"
                    }, 
                    "name": "Bristol Royal Infirmary"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clydebank", 
                        "country": "United Kingdom", 
                        "zip": "G81 4HX"
                    }, 
                    "name": "Golden Jubilee National Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Austria", 
                "China", 
                "Denmark", 
                "France", 
                "Germany", 
                "Israel", 
                "Italy", 
                "Portugal", 
                "Spain", 
                "Sweden", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "RELIANCE 4-FRONT\u2122 Active Fixation Defibrillation Lead Post Market Clinical Follow-Up (PMCF) Study", 
        "other_outcome": [
            {
                "description": "Lead-related Complication-Free Rate from 3 Months through 24 Months Post-Implant", 
                "measure": "Complication Free Rate", 
                "safety_issue": "No", 
                "time_frame": "3 Months through 24 Months Post-Implant"
            }, 
            {
                "description": "Pacing Threshold at 0.5 ms pulse width at 3 Months Post-Implant", 
                "measure": "Pacing Threshold", 
                "safety_issue": "No", 
                "time_frame": "3-months post-implant"
            }, 
            {
                "description": "Sensed Amplitude at 3 Months Post-Implant", 
                "measure": "Sensed Amplitude", 
                "safety_issue": "No", 
                "time_frame": "3 Months Post-Implant"
            }, 
            {
                "description": "Pacing Impedance at 3 Months Post-Implant", 
                "measure": "Pacing impedance", 
                "safety_issue": "No", 
                "time_frame": "3 Months Post-Implant"
            }
        ], 
        "overall_official": {
            "affiliation": "University Hospital Pisa, Italy", 
            "last_name": "Maria Grazia Bongiorni, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Denmark: Danish Medicines Agency", 
                "Portugal: Ethics Committee for Clinical Research", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Lead-related Complication-Free Rate (CFR) from Implant through 3 Months Post-Implant.", 
            "measure": "complication free rate", 
            "safety_issue": "No", 
            "time_frame": "3-months follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01772576"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Lead-related Complication-Free Rate from 3 Months through 15 Months Post-Implant.", 
            "measure": "Complication Free Rate", 
            "safety_issue": "No", 
            "time_frame": "3 months through 15 months post implant"
        }, 
        "source": "Boston Scientific Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boston Scientific Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}